SAMANTHA LYNCH: Open Payments
NPI 1508551326 · OAK BROOK, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,050 in 83 payments from 14 companies in 2025. Trend: 2023 $1,626 · 2024 $2,067 · 2025 $2,050
Food & beverage: $2,050
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 12 | $347 |
| Axsome Therapeutics, Inc. | 10 | $309 |
| Lundbeck LLC | 16 | $303 |
| Otsuka America Pharmaceutical, Inc. | 6 | $251 |
| Alkermes, Inc. | 8 | $166 |
| ABBVIE INC. | 6 | $166 |
| Tris Pharma Inc | 7 | $153 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $120 |
| Corium, LLC | 6 | $86 |
| Neurocrine BioSciences, Inc. | 2 | $42 |
Products named: REXULTI, SPRAVATO, Auvelity, VRAYLAR, Dyanavel XR, LYBALVI, CAPLYTA, Azstarys.
Industry payments across IL — which companies pay providers there.
